- The concentration of the cleaved suPAR forms in pre- and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study.
- Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
- Evaluation of algorithm development approaches: Development of biomarker panels for early detection of colorectal lesions.
- Genome-wide cell-free DNA fragmentation in patients with cancer.
- Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?
- Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers?
- Triage for selection to colonoscopy?
- Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer.
- Direct detection of early-stage cancers using circulating tumor DNA.
- Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects.
